Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma

Noriko Kimura1, Kazuhiro Takekoshi, Akira Horii

  • 1Pathology Division, Department of Clinical Research National Hospital Organization, Hakodate Hospital, 18-16 Kawahara, Hakodate, Hokkaido, 041-8512 Japan Division of Sports Medicine, Faculty of Medicine University of Tsukuba, Tsukuba Japan Division of Molecular Pathology, Department of Pathology School of Medicine, Tohoku University, Sendai Japan Division of Nephrology, Endocrinology and Vascular Medicine Department of Medicine, School of Medicine, Tohoku University, Sendai Japan Department of Breast and Endocrine Surgery, Aichi Medical School of Medicine, Nagoya Japan Department of Endocrinology and Metabolism Hamamatsu Medical School, Hamamatsu Japan Division of Thoracic Surgery, Department of Thoracic and Cardiovascular Surgery Kansai Medical University, Hirakata Japan Department of Diabetes, Endocrinology and Metabolism Fukushima Medical School, Fukushima Japan First Department of Internal Medicine, School of Medicine University of Occupational and Environmental Health, Kitakyusyu Japan Department of Medicine and Molecular Science Graduate School of Medicine, Gunma University, Maebashi Japan Department of Surgery, Nippon Telegraph and Telephone East Corporation Medical Center, Tokyo Japan Department of Internal Medicine School of Medicine, Keio University, Tokyo Japan Genetic Counseling Clinic National Cancer Center, Tokyo Japan Department of Oncology Musashino Red Cross Hospital, Tokyo Japan Department of Breast and Endocrine Surgery Mitsui Memorial Hospital, Tokyo Japan Department of Endocrinology and Metabolism Japan Labour Health and Welfare Organization, Yokohama Rosai Hospital, Yokohama Japan Department of Endocrinology, Metabolism and Hypertension National Hospital Organization Kyoto Medical Center, Kyoto Japan.

Abstract

No abstract available in PubMed .

Related Concept Videos

Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla01:27

Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla

The sympathetic pathways of the collateral ganglia and adrenal medulla serve unique but interconnected roles in the sympathetic response.
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
3.2K
Sympathetic Pathways: Sympathetic Chain Ganglia01:20

Sympathetic Pathways: Sympathetic Chain Ganglia

The sympathetic chain ganglia, also known as the sympathetic trunk ganglia or paravertebral ganglia, are a series of ganglia located bilaterally on either side of the spinal column. These ganglia serve as relay stations for the sympathetic nervous system. Preganglionic neurons originating in the spinal cord project their axons to the sympathetic chain ganglia. Within the ganglia, these preganglionic fibers synapse with postganglionic neurons.The postganglionic neurons of the sympathetic trunk...
7.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110